The Swedish BioFINDER Sleep Study

Recruiting Observational Study
Parkinson´s Disease REM Sleep Behavior Disorder (iRBD) Lewy Body Disease Synucleinopathy Synucleinopathies
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 100
Sex
Any
Study type
Observational
Participants needed
650 (estimated)
Sponsor
Skane University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
BioFINDER-Sleep study was established in 2021 and will include patients with early Parkinson´s disease (PD) and persons with iRBD to provide essential insights into the underlying mechanisms of the progressive neurodegenerative processes in central and peripheral nervous systems. Briefly polysomnography will be used to establish the presence of RBD in both the early PD cohort and in the iRBD cohor…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Idiopathic RBD: * Polysomnography verified RBD according to AASM criteria. * Does not fulfill diagnostic criteria for idiopathic Parkinson´s disease. * Age range 50-100. Women who are \<55 years of age will be required to take a pregnancy test before participation in the PET an…
Contacts

Erik Stomrud, MD, PhD

+46 40 33 10 00

erik.stomrud@med.lu.se

CONTACT

Adjmal Nahimi, MD, PhD

+46 40 33 10 00

adjmal.nahimi@med.lu.se

CONTACT